Selectis Health (GBCS) Short Interest Ratio & Short Volume

Short interest is the volume of Selectis Health shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 600 shares of GBCS short. Learn More on Selectis Health's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GBCS shares currently have a short interest ratio of 2.0. Learn More on Selectis Health's short interest ratio.

Selectis Health saw a increase in short interest in November. As of November 15th, there was short interest totaling 600 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Selectis Health: Artelo Biosciences, Inc. (0.45%), Leafly Holdings, Inc. (1.15%), MyMD Pharmaceuticals, Inc. (5.74%), Lipella Pharmaceuticals Inc. (1.24%), Ensysce Biosciences, Inc. (0.60%), Shineco, Inc. (0.09%), Helius Medical Technologies, Inc. (8.53%), Intellipharmaceutics International Inc. (0.09%), BIOLASE, Inc. (7.46%), Kazia Therapeutics Limited (1.59%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Enbridge Inc. ($4.34 billion), Occidental Petroleum Co. ($4.15 billion), T. Rowe Price Group, Inc. ($2.41 billion), Diamondback Energy, Inc. ($2.05 billion), Coinbase Global, Inc. ($1.75 billion), Lucid Group, Inc. ($1.66 billion), PG&E Co. ($1.62 billion), Rivian Automotive, Inc. ($1.62 billion), Etsy, Inc. ($1.61 billion), and Old Dominion Freight Line, Inc. ($1.60 billion). View all of the most shorted stocks.

Short selling GBCS is an investing strategy that aims to generate trading profit from Selectis Health as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Selectis Health occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GBCS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GBCS, twice per month. The most recent reporting period available is November, 15 2022.